Alan M. Krensky
Director, Office of Portfolio Analysis and Strategic Initiatives (OPASI)
Deputy Director, National Institutes of Health
United States Department of Health and Human Services

Alan M. Krensky, MD, is the first NIH Deputy Director for the Office of Portfolio Analysis and Strategic Initiatives (OPASI) and began his position on July 8, 2007. TheOPASI was built on the success of the NIH Roadmap for Medical Research and has two goals: to identify important areas of emerging scientific opportunities or rising public health challenges, and to help accelerate investments in these areas to make sure new ideas have a chance to develop. OPASI provides new opportunity for more trans-NIH dialogue, decision-making, and funding for scientific priorities and opportunities that would be difficult to support otherwise.

Dr. Krensky graduated from the University of Pennsylvania in 1973, and received his M.D. from the University of Pennsylvania in 1977. At the Stanford University School of Medicine, Dr. Krensky most recently served as professor of pediatrics, Chief of the Division of Immunology and Transplantation Biology, Associate Chair for Research in the Department of Pediatrics, and Associate Dean for Children's Health.

Dr. Krensky's research interests are in human cellular and molecular immunology, transplantation immunology, and tumor immunology. He is a member of the American Society for Clinical Investigation and the Association of American Physicians and is a co-author of more than 240 research papers.

Dr. Krensky has received numerous awards, including the Young Investigator Award from the Society for Pediatric Research, the Young Investigator Award from the American Society of Nephrology/American Heart Association, the Joseph A. Shankman Award from the National Kidney Foundation of Massachusetts, the Young Investigator Award from the American Society for Histocompatibility and Immunogenetics, the Award for Excellence in Pediatric Research from the American Academy of Pediatrics, the Scholar in Experimental Therapeutics Award from the Burroughs Wellcome Fund, the E. Mead Johnson Award from the Society for Pediatric Research, and the Novartis Established Investigator Award from the American Society for Transplantation.